|
|
||||||||
The Journal of Immunology, Vol 136, Issue 3 860-866, Copyright © 1986 by American Association of Immunologists
ARTICLES |
DA Bass, P Olbrantz, P Szejda, MC Seeds and CE McCall
Stimulated human polymorphonuclear leukocytes (PMNL) have a marked increase in oxidative metabolism, producing reduced oxygen species (e.g., H2O2) that mediate bacterial killing. Previously, quantitation of metabolic responses of PMNL from patients with acute infections employed assays that measure mean activity of the entire PMNL population; such studies reported a modest and highly variable increase in oxidative metabolic responses of such "toxic" PMNL compared with normal cells. To assess metabolic capability of PMNL from 51 patients with acute bacterial infection, we employed a quantitative flow cytometric assay of H2O2-dependent oxidative product formation, the intracellular oxidation of 2',7'-dichlorofluorescin (DCFH). After stimulation by phorbol myristate acetate, the PMNL of patients demonstrated an increase in mean DCFH oxidation (315 +/- 14 and 180 +/- 4.5 amol/cell, patients and controls). Hexose monophosphate shunt activation was similarly increased in stimulated PMNL from bacteremic patients. These data are comparable with previous studies of mean metabolic activities of toxic PMNL. However, these mean values underestimate the quantitative responses of the hyperresponsive ("primed") PMNL within a mixture of normal and primed PMNL in the patients' blood. The flow cytometric assay demonstrated that the PMNL of the patients were composed of two populations. One population of PMNL had normal oxidative responses; the other "primed" population had up to 4.6 times the oxidative product formation of normal cells. Similar priming of circulating PMNL was caused by infection with gram- positive or gram-negative staining bacteria or by Candida species. The proportion and oxidative ability of the primed PMNL occurred independently of the number of juvenile neutrophil forms and independently of "toxic" morphologic changes of Wright's-stained PMNL. On the average, 40% of the PMNL of patients were primed, but the size of the primed PMNL population varied widely between patients (range 0 to 80%). This variable subpopulation may explain the variability of mean responsiveness of the PMNL of patients reported previously. Moreover, the marked increase in oxidative metabolic capability of the primed PMNL may be a significant component of the host response to acute infection. It could also contribute to the damage to host tissues such as pulmonary vascular endothelium during bacteremia.
This article has been cited by other articles:
![]() |
J. G. Moreland, A. P. Davis, J. J. Matsuda, J. S. Hook, G. Bailey, W. M. Nauseef, and F. S. Lamb Endotoxin Priming of Neutrophils Requires NADPH Oxidase-generated Oxidants and Is Regulated by the Anion Transporter ClC-3 J. Biol. Chem., November 23, 2007; 282(47): 33958 - 33967. [Abstract] [Full Text] [PDF] |
||||
![]() |
S H Choi, S W Lee, Y S Hong, J M Jeun, and B W Min Selective inhibition of polymorphonuclear neutrophils by resuscitative concentration of hypertonic saline Emerg. Med. J., February 1, 2006; 23(2): 119 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Brown, M. Q. Stewart, S. A. Bissonnette, A. E. H. Elia, E. Wilker, and M. B. Yaffe Distinct Ligand-dependent Roles for p38 MAPK in Priming and Activation of the Neutrophil NADPH Oxidase J. Biol. Chem., June 25, 2004; 279(26): 27059 - 27068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Hollmann, K. Kurz, S. Herroeder, D. Struemper, K. Hahnenkamp, N. S. Berkelmans, C. G. den Bakker, and M. E. Durieux The Effects of S(-)-, R(+)-, and Racemic Bupivacaine on Lysophosphatidate-Induced Priming of Human Neutrophils Anesth. Analg., October 1, 2003; 97(4): 1053 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fazal, W. M. Al-Ghoul, M. A. Choudhry, and M. M. Sayeed PAF receptor antagonist modulates neutrophil responses with thermal injury in vivo Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1310 - C1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.T. MASCELLINO, G. DELOGU, M.R. PELAIA, R. PONZO, R. PARRINELLO, and A. GIARDINA Reduced bactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa of blood neutrophils from patients with early adult respiratory distress syndrome J. Med. Microbiol., January 1, 2001; 50(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Elbim, S. Pillet, M. H. Prevost, A. Preira, P. M. Girard, N. Rogine, H. Matusani, J. Hakim, N. Israel, and M. A. Gougerot-Pocidalo Redox and Activation Status of Monocytes from Human Immunodeficiency Virus-Infected Patients: Relationship with Viral Load J. Virol., June 1, 1999; 73(6): 4561 - 4566. [Abstract] [Full Text] |
||||
![]() |
C. J. Clark, F. Boswell, I. A. Greer, and F. Lyall Treatment of Endothelial Cells With Serum from Women with Preeclampsia: Effect on Neutrophil Adhesion Reproductive Sciences, January 1, 1997; 4(1): 27 - 33. [Abstract] [PDF] |
||||
![]() |
R. A. Ward, M. Nakamura, and K. R. McLeish Priming of the Neutrophil Respiratory Burst Involves p38 Mitogen-activated Protein Kinase-dependent Exocytosis of Flavocytochrome b558-containing Granules J. Biol. Chem., November 17, 2000; 275(47): 36713 - 36719. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |